Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

Journal Title: Turkish Journal of Hematology - Year 2019, Vol 36, Issue 3

Abstract

.

Authors and Affiliations

Müfide Okay, Sıla Çetik, İbrahim C. Haznedaroğlu

Keywords

Related Articles

Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton’s Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells

Objective: Mesenchymal stem cells (MSCs), which possess immunosuppressive characteristics on induced T-cells, were shown to be applicable in prevention and treatment of graft-versus-host disease. However, knowledge of ef...

TNF-α-308 G/A Polymorphism in Egyptian Budd-Chiari Syndrome Patients

To the Editor, Budd-Chiari syndrome (BCS) is an uncommon condition induced by thrombotic or non-thrombotic obstruction of hepatic venous outflow. BCS most often occurs in patients with underlying thrombotic diathesis, i...

Download PDF file
  • EP ID EP642947
  • DOI 10.4274/tjh.galenos.2019.2019.0113
  • Views 85
  • Downloads 0

How To Cite

Müfide Okay, Sıla Çetik, İbrahim C. Haznedaroğlu (2019). Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia. Turkish Journal of Hematology, 36(3), 218-219. https://europub.co.uk/articles/-A-642947